HighGravityDataCardinal Health — Apr 30, 2026 release
Fiscal 2026 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000721371-26-000017
Showing in the filing
Targeted leverage range
“2.75 - 3.25X”
Period
The long term
Measure
Company-defined measure
Source
Prose
All guidance in this release · 9
For non-GAAP diluted EPS attributable to Car… for FY2026
“$10.70 to $10.80 (+30% to +31% growth)”
Non-GAAP diluted EPS for FY2026
“$10.70 to $10.80 (+30% to +31% growth)”
Pharmaceutical and Specialty Solutions segme… for FY2026
“22% to 23%”
Other segment profit growth for FY2026
“36% to 38%”
Non-GAAP effective tax rate for FY2026
“approximately 19%”
Diluted weighted average shares outstanding for FY2026
“approximately 237 million”
Interest and Other expense for FY2026
“approximately $340 million”
Adjusted free cash flow for FY2026
“$3.3 billion to $3.7 billion”
Targeted leverage range for the long term
“2.75 - 3.25X”
Exhibit 99.1 · the passage around this item
… earlier in the release
Patients will receive care at community gastroenterology clinics across the country with Specialty Networks performing the analysis of the results. • Cardinal Health reduced debt, completing $100M term loan payment ahead of schedule and lowered its leverage ratio 5 to 3.0X, maintaining its targeted range of 2.75 - 3.25X and its investment grade rating. • Cardinal Health recently completed an additional $250 million accelerated share repurchase program, bringing year-to-date share repurchases in fiscal year 2026 to $1.0 billion. Cardinal Health Page 4 Webcast Cardinal Health will host a webcast today at 8:30 a.m. ET to discuss third quarter results. To access the webcast and corresponding slide presentation, go to the Investor Relations page at ir.cardinalhealth.com . No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months. About Cardinal Health Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company’s customer-centric focus drives continuous improvement and leads to innovative solutions that improve people’s lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom . Contacts Media: Erich Timmerman, Eri
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.